SageView Advisory Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
SageView Advisory Group's PFE Position: Q4 2025 in Review
SageView Advisory Group increased its Pfizer (PFE) stake by 6.5% in Q4 2025, buying an estimated $96.3K and bringing the position to 62,717 shares worth $1.56M. The position accounts for 0.05% of the portfolio, ranked #195.
SageView Advisory Group first reported a position in PFE in Q4 2022 and has held it in 12 quarters since. 2,906 funds tracked by Wall St. Rank hold PFE as of Q4 2025.
- SageView Advisory Group held 62,717 shares of Pfizer worth $1.56M as of Q4 2025.
- SageView Advisory Group bought 3,820 Pfizer shares in Q4 2025, an estimated $96.3K.
- Pfizer made up 0.05% of SageView Advisory Group's portfolio in Q4 2025, its #195 holding.
- SageView Advisory Group first reported a position in Pfizer in Q4 2022 and has held it in 12 quarters since.
- 2,906 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.
Based on SageView Advisory Group's 13F filing for Q4 2025, filed 17 Feb 2026.